Article Details

AstraZeneca Pharma gets CDSCO nod for Trastuzumab deruxtecan use for 2 more indications

Retrieved on: 2024-03-29 16:17:37

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Pharma gets CDSCO nod for Trastuzumab deruxtecan use for 2 more indications. View article details on hiswai:

Excerpt

AstraZeneca Pharma India receives CDSCO approval to import Trastuzumab deruxtecan for HER2-low breast cancer and HER2 positive gastric cancer.

Article found on: www.thehindu.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up